Onconetix (ONCO) EBIAT (2023 - 2025)
Historic EBIAT for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$8.8 million.
- Onconetix's EBIAT fell 12949.5% to -$8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.1 million, marking a year-over-year increase of 477.33%. This contributed to the annual value of -$58.7 million for FY2024, which is 5688.72% down from last year.
- According to the latest figures from Q3 2025, Onconetix's EBIAT is -$8.8 million, which was down 12949.5% from -$2.4 million recorded in Q2 2025.
- In the past 5 years, Onconetix's EBIAT registered a high of -$2.4 million during Q2 2025, and its lowest value of -$29.4 million during Q4 2024.
- Its 3-year average for EBIAT is -$10.5 million, with a median of -$8.5 million in 2025.
- As far as peak fluctuations go, Onconetix's EBIAT plummeted by 29058.53% in 2024, and later soared by 8341.73% in 2025.
- Over the past 3 years, Onconetix's EBIAT (Quarter) stood at -$22.4 million in 2023, then plummeted by 31.71% to -$29.4 million in 2024, then skyrocketed by 70.16% to -$8.8 million in 2025.
- Its last three reported values are -$8.8 million in Q3 2025, -$2.4 million for Q2 2025, and -$8.5 million during Q1 2025.